• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A process for producing a pyrazole compound of the general formula (5) comprises reacting a 2-acyl-3-aminoacrylic acid ester of the general formula (1) with a hydrazine of the general formula (4) in the presence of a base wherein R 1, R 2, R 3 and R 4 each independently represent an alkyl group wherein R 5 represents an alkyl group or an aryl group, wherein R 1, R 4 and R 5 have the same meanings as above. By this production method, it is possible to produce the 1,3-disubstituted pyrazole-4-carboxylic acid ester with high yield and selectivity and less discoloration.
    公开号:CH706864B1
    申请号:CH02093/13
    申请日:2012-06-18
    公开日:2016-03-31
    发明作者:Masamune Okamoto；Hideaki Imura；Naoto Takada
    申请人:Central Glass Co Ltd；
    IPC主号:
    专利说明:

    Technical area
    The present invention relates to a process for the preparation of a pyrazole compound which can be used as an intermediate for pharmaceutical and agrochemical products.
    State of the art
    There have been known many processes for producing a 1,3-disubstituted pyrazole-4-carboxylic acid ester by reacting a 2-alkoxymethylene acylacetate in which an alkoxy group functions as a leaving group with a hydrazine (see, for example, Patent Documents 1 to 3). For example, Patent Document 3 discloses that a mixture of isomers is composed of ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate and ethyl 5- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate an aqueous solution of ethyl 2-ethoxymethylene-4,4-difluoroacetoacetate and methylhydrazine can be obtained.
    On the other hand, methods for producing a 1,3-disubstituted pyrazole-4-carboxylic acid ester by reacting a reaction substrate in which an amino group functions as a leaving group have been proposed. For example, Patent Document 4 discloses that a 3-perhalo-substituted pyrazole can be obtained by reacting a 2-perhaloacyl-3-aminoacrylic acid derivative with a hydrazine. Patent Document 5 discloses that an 89.2: 10.8 mixture of ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate and its isomer (ethyl 5- (difluoromethyl) -1- methyl 1H-pyrazole-4-carboxylate) can be obtained by reacting ethyl 2- (difluoroacetyl) -3- (dimethylamino) acrylate with methylhydrazine.
    Prior art documents
    Patent documents
    Patent Document 1: Japanese Patent Laid-Open Publication No. 2000-128,763
    Patent Document 2: Japanese Patent Laid-Open Publication No. 2000-212166
    Patent Document 3: Publication of International Patent Application No. 06/090 778
    Patent Document 4: Published Japanese Translation of Publication of International Application No. 2005-511782
    Patent Document 5: Published Japanese Translation of Publication of International Application No. 2007-509,850.
    Summary of the invention
    Problems to be solved by the invention
    In the case of producing ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate by the method of Patent Document 5, the resulting product has discoloration. Although the cause of such discoloration is not clear, the presence of an unidentified substance is suspected due to the fact that both 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate and its isomer, i.e. ethyl 5- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate, are solid and colorless. In order to use the pyrazole compound as an intermediate for pharmaceutical and agrochemical products, it is not desirable that the unidentified substance is contained in the pyrazole compound even in a small amount.
    [0010] Accordingly, it is an object of the present invention to produce a 1,3-disubstituted pyrazole-4-carboxylic acid ester with less discoloration.
    Means for solving the tasks
    The inventors of the present invention have found that in the case of producing 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate according to the method of Patent Document 5, it is possible for discoloration to occur in the significantly reducing the resulting product by adding ethyl 2- (difluoroacetyl) -3- (dimethylamino) acrylate to methylhydrazine in toluene, etc. in the presence of a base. The present invention is based on this finding. Despite the fact that an ester such as ethyl 2- (difluoroacetyl) -3- (dimethylamino) acrylate is easily hydrolyzed on contact with an aqueous basic solution, hydrolysis does not occur under the reaction conditions of the present invention - (Difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate can be obtained with high yield.
    It is therefore conceivable to produce ethyl 2- (difluoroacetyl) -3- (dimethylamino) acrylate using a dialkylaminoacrylic acid ester as the starting material. In this case, the production of ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate takes place in the following first and second steps: acylation and cyclization:
    In the acylation of the first step (acylation step), an organic base, for example triethylamine, is often added to prevent the formation of a trimesic acid ester. Since hydrogen halide as an acidic component is produced as a by-product in acylation, the organic base, for example triethylamine, is combined with an acid produced as a by-product to form a salt of the organic base and hydrogen halide (hereinafter sometimes referred to simply as "salt") to build.
    The inventors of the present invention made researches on the influence of the salt on the cyclization and found that: the presence of the salt leads to an increase in the production of the isomer (1,5-disubstituted pyrazole-4-carboxylic acid ester), and that the ratio of the isomer can be reduced by purifying, for example, washing with water and drying the reaction solution obtained by the acylation step. However, the yield of the acylation reaction product is reduced by such a purification process. This leads to a deterioration in the target product yield. The inventors of the present invention found, as a result of further research, that it is possible to obtain the 1,3-disubstituted pyrazole-4-carboxylic acid ester in high yield, with less isomer, by cyclizing the second step (cyclization step) after the addition an inorganic base such as potassium hydroxide to the reaction solution obtained by the acylation step without removing the salt from the reaction solution.
    Namely, the present invention includes the following aspects.
    [Aspect 1 of the Invention]
    A process for producing a pyrazole compound of the general formula (5), comprising: a reaction step of reacting a 2-acyl-3-amino-acrylic acid ester of the general formula (1) with a hydrazine of the general formula (4) in the presence of a base
    wherein R 1, R 2, R 3 and R 4 each independently represent an alkyl group,
    wherein R <5> represents an alkyl group or an aryl group,
    in which R 1, R 4 and R 5 have the same meanings as above.
    [Aspect 2 of the Invention]
    The method for producing a pyrazole compound according to aspect 1 of the invention, wherein the base is an inorganic base.
    [Aspect 3 of the Invention]
    The method for producing a pyrazole compound according to aspect 2 of the invention, wherein the base is an alkali metal hydroxide.
    [Aspect 4 of the Invention]
    The method for producing a pyrazole compound according to one of the inventive aspects 1 to 3, wherein R <1> is a halogenated alkyl group having 1 to 10 carbon atoms.
    [Aspect 5 of the Invention]
    The method for producing a pyrazole compound according to aspect 4 of the invention, wherein R 1 is a fluoroalkyl group having 1 to 4 carbon atoms.
    [Aspect 6 of the Invention]
    The process for producing a pyrazole compound according to aspect 5 of the invention, wherein R 1 is a trifluoromethyl group or a difluoromethyl group.
    [Aspect 7 of the Invention]
    The process for producing a pyrazole compound according to aspect 4 of the invention, wherein R <1> is a chloroalkyl group having 1 to 4 carbon atoms.
    [Aspect 8 of the Invention]
    The process for producing a pyrazole compound according to aspect 7 of the invention, wherein R 1 is a dichloromethyl group.
    [Aspect 9 of the Invention]
    The process for the preparation of the pyrazole compound according to one of the inventive aspects 1 to 8, wherein the reaction step comprises the following second steps (sub-steps):a first step of obtaining a reactor content containing the 2-acyl-3-aminoacrylic acid ester of the general formula (1) by reacting a carboxylic acid halide of the general formula (2) with a dialkylaminoacrylic acid ester of the general formula (3) in the presence of an organic base
    wherein R <1> has the same meaning as in the general formula (1),
    wherein R 2, R 3 and R 4 have the same meanings as in general formula (1), anda second step of forming a pyrazole compound of the general formula (5) by mixing the reactor contents obtained by the first step, an inorganic base as the base and a substituted hydrazine as the hydrazine of the general formula (4).
    [Aspect 10 of the Invention]
    The method for producing a pyrazole compound according to the invention aspect 9, wherein in the second step, the pyrazole compound of the general formula (5) by mixing a composition containing the reactor content obtained by the first step and the Base contains, is formed with a composition containing the substituted hydrazine.
    [Aspect 11 of the Invention]
    The process for producing a pyrazole compound according to aspects 9 or 10 of the invention, wherein the organic base used in the first step is a tertiary amine, and wherein the inorganic base used in the second step is either potassium hydroxide or sodium hydroxide.
    [Aspect of the Invention 12]
    The process for the preparation of a pyrazole compound according to one of the inventive aspects 9 to 11, wherein the carboxylic acid halide of the general formula (2) is difluoroacetic acid fluoride.
    In the present invention, it is possible to produce the 1,3-disubstituted pyrazole-4-carboxylic acid ester with high yield and selectivity and with less discoloration. In addition, the content of an isomer (1,5-disubstituted pyrazole-4-carboxylic acid ester) in the product in the present invention can be limited to a very low level. In particular, in a preferred embodiment of the present invention, the 1,3-disubstituted pyrazole-4-carboxylic acid ester can efficiently have less isomer by acylating a dialkylaminoacrylic acid ester as a starting material in the presence of an organic base and then by cyclizing the acylation reaction product after adding an inorganic base to the reactor contents can be produced without removing a salt from the reactor contents.
    Detailed description of the embodiments
    In the following, the present invention will be described in detail.
    In the following description, a 1,3-disubstituted pyrazole-4-carboxylic acid ester and a 1,5-disubstituted pyrazole-4-carboxylic acid ester can be used as "1,3-isomer" and "1,5-isomer" for the purpose to distinguish a pyrazole compound with 1,3-substituents from a pyrazole compound with 1,5-substituents. However, these abbreviations are not intended to designate specific pyrazole compounds. In addition, the term "alkyl group" refers to either a straight, branched, or cyclic alkyl group, and the terms "alkyl group" and "aryl group" refer to alkyl and aryl groups with or without substituents.
    <Synthesis of 2-acyl-3-aminoacrylic acid ester (acylation)>
    A 2-acyl-3-aminoacrylic acid ester of the general formula (1) is synthesized by reaction (acylation) of a carboxylic acid halide of the general formula (2) and a dialkylaminoacrylic acid ester of the general formula (3).
    In the general formulas (1) to (3), R 1, R 2, R 3 and R 4 each independently represent an alkyl group. The alkyl group preferably has 1 to 10 carbon atoms and particularly preferably 1 to 4 carbon atoms. In addition, the alkyl group may have replaced a hydrogen atom or hydrogen atoms with a halogen atom. As for the halogen atom, fluorine, chlorine, bromine or iodine can be used. Among others, fluorine or chlorine is preferred as the halogen atom. Examples of the alkyl group are methyl, ethyl, n-propyl, isopropyl, n-butyl, s-butyl, t-butyl, cyclohexyl, cyclopentyl and those obtained by replacing any hydrogen atom of these alkyl groups with a halogen atom.
    R 1 is preferably a halogenated alkyl group having 1 to 4 carbon atoms, particularly preferably a fluoroalkyl, chloroalkyl or chlorofluoroalkyl group having 1 to 4 carbon atoms. Specific examples of the halogenated alkyl group are trifluoromethyl, difluoromethyl, monofluoromethyl, pentafluoromethyl, 2,2,2-trifluoroethyl, 2,2-difluoromethyl, 1,1,2,2-tetrafluoroethyl, trichloromethyl, dichloromethyl, monochloromethyl, pentachloroethyl, 2,2 , 2-trichloroethyl, 2,2-dichloroethyl, 1,1,2,2-tetrachloroethyl, chlorodifluoromethyl and dichlorofluoromethyl. Trifluoromethyl, difluoromethyl or dichloromethyl is particularly preferred among others.
    There is no particular restriction on R 2 and R 3 because R 2 and R 3 function as a leaving group NR 2 R 3. Each of R 2 and R 3 can be halogen-substituted. Among the above alkyl groups, methyl or ethyl is preferred as R 2, R 3. It is particularly preferred that both R 2 and R 3 are methyl.
    R 4 is determined depending on the purpose of the reaction using the pyrazole compound as a reaction substrate. When the pyrazole compound is converted to a carboxylic acid by deprotection of R <4>, R <4> functions as a leaving group. In this case, there is no particular restriction on R <4>. Among the above alkyl groups, ethyl or isopropyl is preferred as R 4.
    In the general formula (2), X represents a halogen atom, for example fluorine, chlorine, bromine or iodine.
    The carboxylic acid halide can be produced by any known method. For example, it is possible to produce a carboxylic acid chloride by chlorinating a corresponding carboxylic acid with a chlorinating agent, for example thionyl chloride, or by oxidizing a halogenated hydrocarbon. It is also possible to produce a carboxylic acid fluoride by thermally decomposing 1-alkoxy-1,1,2,2-tetrafluoroethane in the presence of a catalyst (see, for example, Japanese Patent Laid-Open Publication No. 8-20,560).
    The acylation is generally carried out in a non-aqueous solvent. As the non-aqueous solvent, an aliphatic or aromatic hydrocarbon can be used. Examples of the non-aqueous hydrocarbon solvent are petroleum ether, n-hexane, n-heptane, cyclohexane, benzene, toluene, xylene, decalin and halogenated hydrocarbons such as chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane and trichloroethane. Toluene, xylene, chlorobenzene, n-hexane or cyclohexane, among others, are preferred. Toluene or xylene is particularly preferred. The above solvents can be used singly or in the form of a mixture thereof.
    In addition, the acylation is generally carried out in the presence of a base. The addition of the base makes it possible to trap a hydrogen halide, for example HF or HCl, which is generated in the acylation, and thereby prevent the generation of a trimesic acid ester as a by-product. As the base, a tertiary amine, a pyridine or a pyridine derivative (hereinafter sometimes referred to as "pyridine") or the like can be used. Examples of the pyridine or pyridine derivative are pyridine, 2-, 3- or 4-methylpyridine, 2-methyl-5-ethylpyridine, 4-ethyl-2-methylpyridine, 3-ethyl-4-methyl-pyridine, 2,4 , 6-collidine, 2- or 4-n-propylpyridine, 2,6-dimethylpyridine (lutidine), 4-dimethylaminopyridine, quinoline and quinaldine. Among others, pyridine, 2-methyl-5-ethylpyridine, 2,4,6-collidine, quinoline or quinaldine are preferred. Pyridine is particularly preferred. Examples of the tertiary amine are: symmetrical tertiary amines, for example trimethylamine, triethylamine, tri-n-propylamine, triisopropylamine, tri-n-butylamine, tri-isobutylamine, tri-sec-butylamine, tri-tert-butylamine, tri-n -amylamine, tri-isoamylamine, tri-sec-amylamine and tri-tert-amylamine, and asymmetric tertiary amines, for example N-methyldi-n-butylamine, N-methyl-diisobutylamine, N-methyldi-tert-butylamine, N, N-diisopropylbutylamine, N, N-dimethyldecylamine, N, N-dimethylundecylamine, N, N-dimethyldodecylamine and N-methyldihexylamine. In view of boiling point, water solubility and availability, it is preferred to use symmetrical amine. Trimethylamine, triethylamine, tri-n-propylamine, triisopropylamine or tri-n-butylamine are preferred among others. Triethylamine is particularly preferred. In the present production process, pyridine or triethylamine is particularly preferred as the base.
    The acylation is carried out at a temperature from -20 ° C to +50 ° C, preferably -10 ° C to +45 ° C, particularly preferably from 0 to 40 ° C. Since the reaction is not influenced by the reaction pressure, there is no particular limitation on the reaction pressure. In general, it suffices to carry out the acylation under pressure conditions of from atmospheric pressure to about 1 MPa, although the acylation can be carried out under pressure conditions of about 0.1 to 10 MPa. The reaction time may vary depending on the reaction temperature and the content ratio of the reagent. The reaction time is generally about 10 minutes to 10 hours. The reaction time can be determined based on the reduction or disappearance of the reaction substrate as a guide by monitoring the progress of the reaction.
    In the acylation, the dialkylaminoacrylic acid ester is used in an amount of 0.5 to 3 mol, preferably 0.5 to 1.5 mol, particularly preferably 0.9 to 1.1 mol, per 1 mol of the carboxylic acid halide. The base is used in an amount of 0.5 to 5 mol, preferably 0.8 to 2 mol, particularly preferably 0.9 to 1.5 mol, per 1 mol of the carboxylic acid halide, although it suffices to add the base in an equimolar amount to use the carboxylic acid halide.
    It is possible to carry out the acylation by dissolving the dialkylaminoacrylic acid ester and the base in the solvent, keeping the resulting solution at a temperature lower than or equal to the upper limit of the reaction temperature, and blowing the carboxylic acid halide into the solution. Alternatively, it is possible to carry out the acylation in a scrubber system. The base can be added continuously or successively as the reaction proceeds.
    The reactor contents (reaction solution) obtained in this way, which contain the 2-acyl-3-aminoacrylic acid ester, can be used in the subsequent cyclization step without purification or after the remaining solvent or the base has been distilled off (for example removal of the solvent by flash distillation) . In the case of using the organic base such as pyridine or trialkylamine for the purpose of preventing the generation of the trimesic acid ester, the organic base forms a salt with the hydrogen halide generated in the acylation. The reactor contents which contain such a salt can be subjected directly to the subsequent cyclization step. However, there is a possibility that the production of an unfavorable isomer (1,5-disubstituted pyrazole-4-carboxylic acid ester) as a by-product is accelerated in the presence of the salt. It is desirable to remove the salt by washing with water, etc. However, by such a water washing operation, the recovery rate of the 2-acyl-3-aminoacrylic acid ester can be decreased because of the high water solubility of the 2-acyl-3-aminoacrylic acid ester.
    <Synthesis of pyrazole compound (cyclization)>
    The 2-acyl-3-aminoacrylic acid ester of the general formula (1) obtained above is reacted with a hydrazine of the general formula (4) in the presence of a base, whereby a pyrazole compound of the general formula (5) is synthesized.
    Since the meanings of R <1>, R <2>, R <3> and R <4> in the general formulas (1) and (5) are the same as above, repeated explanations of R <1>, R 2, R 3 and R 4 are omitted.
    In the general formulas (4) and (5), R <5> represents an alkyl or aryl group which may have a substituent. R 5 is preferably a straight-chain, branched or cyclic alkyl or alkoxyalkyl group having 1 to 10 carbon atoms or an aryl group. Any number of hydrogen atoms in the alkyl or alkoxy group can be replaced by a halogen atom. An oxygen atom of the alkoxy group can be replaced by a sulfur atom. Fluorine, chlorine or bromine can be used as the halogen atom. Specific examples of the alkyl or aryl group as R 5 are methyl, ethyl, n-propyl, isopropyl, tert-butyl, difluoromethyl, trifluoromethyl, hydroxymethyl, hydroxyethyl, cyclopropyl, cyclopentyl, cyclohexyl and phenyl. Methyl, ethyl, isopropyl, n-propyl or tert-butyl is preferred among others. Methyl is particularly preferred.
    Preferred examples of the hydrazine represented by the general formula (4) are substituted hydrazines such as methyl hydrazine and ethyl hydrazine. It is advantageous to use the hydrazine in solution form in terms of availability and ease of use, although the hydrazine can be used in anhydrous form.
    The cyclization is carried out in the presence of the base. As the base, a water-soluble inorganic base is suitably used. The inorganic base is preferably an alkaline earth metal or alkali metal hydroxide, carbonate or hydrogen carbonate. It is particularly advantageous to use an alkali metal hydroxide as the base. Specific examples of the base are sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, potassium hydrogen carbonate and sodium hydrogen carbonate. Among others, sodium hydroxide, potassium hydroxide or lithium hydroxide is preferred. Sodium hydroxide or potassium hydroxide is more preferred. Potassium hydroxide is particularly preferred because of its high solubility in aqueous solvents and its ease of use, for example cleaning. The base used does not necessarily have a high purity quality. It is economical to use the general-purpose grade base available as a common industrial chemical or common industrial reagent.
    In the cyclization, the base is generally used in an amount of 0.05 to 2 mol, preferably 0.2 to 0.6 mol, particularly preferably 0.3 to 0.5 mol, per 1 mol of the 2 -Acyl-3-aminoacrylic acid ester used. When the amount of the base used is less than 0.05 mol, the decolorization effect may be low. If the amount of the base used exceeds 2 moles, the yield of the target product may be lowered due to hydrolysis of the starting material or the reaction product.
    It is a preferred embodiment of the present invention to carry out the acylation by using the organic base and thereafter carry out the cyclization by adding the inorganic base to the resulting reactor contents without removing the salt from the reactor contents. In general, the formation amount of the isomer (1,5-disubstituted pyrazole-4-carboxylic acid ester) is increased in the presence of the salt in the cyclization reaction system. In the preferred embodiment of the present invention, however, it is possible to limit the amount of formation of the isomer (1,5-disubstituted pyrazole-4-carboxylic acid ester) to a low level if the cyclization is effected by the addition of the inorganic base without removing the salt from the Reaction system is carried out. In this preferred embodiment, it is advantageous to use a tertiary amine as the organic base in the cyclization and to use potassium hydroxide or sodium hydroxide as the inorganic base in the cyclization. In addition, it is possible in the cyclization to use the inorganic base in an amount of 1.1 to 1.3 mol, preferably 1.2 to 2 mol, particularly preferably 1.3 to 1.5 mol, per 1 mol of the 2- Acyl-3-aminoacrylic acid ester to be used in this preferred embodiment. If the amount of the inorganic base used is less than 1.1 mol, the retarding effect for the 1,5-isomer may be poor. If the amount of the inorganic base used exceeds 3 mol, the yield of the target product may be decreased due to hydrolysis of the starting material or the reaction product. It is also advantageous to use difluoroacetic acid fluoride as the carboxylic acid halide of the general formula (2).
    The cyclization is preferably carried out in the presence of a solvent. Examples of the solvent are: water; aliphatic, alicyclic or aromatic hydrocarbons, for example petroleum ether, n-hexane, n-heptane, cyclohexane, benzene, toluene, xylene and decalin; halogenated hydrocarbons, for example chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane and trichloroethane; Ethers, for example diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane and anisole; Alcohols, for example methanol, ethanol, n-propanol, isopropanol, n-butanol, i-butanol, s-butanol, t-butanol and cyclohexanol; Ketones, for example acetone, methyl ethyl ketone, methyl isobutyl ketone and cyclohexanone; Nitriles, for example acetonitrile, propionitrile, n- or isobutyronitrile and benzonitrile; Amides, for example N, N-dimethylformamide, N, N-dimethylacetamide, N, N-methylformanilide, N-methylpyrrolidone and hexamethylphosphoramide, sulfoxides, for example dimethyl sulfoxide, and sulfolanes, for example sulfolane. Among others, a hydrocarbon or halogenated hydrocarbon solvent is preferred. Particularly preferred is an aromatic hydrocarbon solvent. As the aromatic hydrocarbon solvent, toluene, xylene, chlorobenzene, n-hexane or cyclohexane is specifically preferred. Toluene or xylene is particularly preferred. In addition, it is advantageous to use the same solvent in this pyrazole synthesis step as that used in the previous step for the synthesis of 2-acyl-3-aminoacrylic acid ester. It is particularly advantageous to use the same solvent in the 2-acyl-3-aminoacrylic acid ester synthesis step and in the pyrazole synthesis step in the case in which the reaction product of the previous step of the synthesis of 2-acyl-3-aminoacrylic acid ester without Separation or purification is subjected to a pyrazole cyclization reaction. The above solvents can be used in the form of a mixture of two or more thereof.
    It is preferred to carry out the cyclization under low temperature conditions. In view of the feasibility, the cyclization is carried out at -78 ° C to +30 ° C, preferably -30 ° C to +20 ° C. However, it is inconvenient to set the cyclization temperature lower than -78 ° C in view of operating difficulties due to solidification or viscosity increase of the solvent, increase in cooling cost, decrease in reaction rate, etc. It is also inconvenient to set the cyclization temperature higher than +30 ° C with a view to the decrease in selectivity due to the occurrence of a side reaction. Since the reaction is not affected by the reaction pressure within a normal range, there is no particular limitation on the reaction pressure. The cyclization can be carried out under pressure conditions or under reduced pressure conditions. In general, it is sufficient to carry out the cyclization under atmospheric pressure conditions without conscious application of pressure or pressure reduction. For safety reasons it is not advantageous to bring the hydrazine, which is a powerful reducing agent, into contact with air. The cyclization is therefore preferably carried out in an atmosphere of nitrogen, argon, etc. The reaction time varies depending on the reaction temperature and the like. The reaction time is generally about 10 minutes to 10 hours.
    In the cyclization reaction, there is no particular limitation on the order of introducing the reaction substrates and auxiliary materials into the reaction system. It is easy to handle the base in the form of a composition containing the base, the hydrazine and the solvent, and thus it is preferable to combine this composition with a composition containing the 2-acyl-3-aminoacrylic acid ester in To bring contact. Of course, the object of the present invention can be achieved by any technique in accordance with such an intention. More specifically, one of the above compositions can preferably be introduced into the other composition by dropping or injection using a metering pump and so on. In the above preferred embodiment, the reactor contents obtained by the acylation step can be mixed with the inorganic base and the substituted hydrazine. It is advantageous to mix a composition containing the reactor contents obtained by the acylation step and the inorganic base with a composition containing the substituted hydrazine. The mixing is preferably carried out gradually so that the reaction temperature does not exceed the upper limit of the above temperature range, the progress of the reaction, for example temperature rise and component change of the reactor contents, being monitored. It is also advantageous to stir the contents of the reactor.
    The pyrazole compound can be purified by an ordinary purification method.
    An example of a cleaning method includes washing the reactor contents with water and distilling the resulting organic phase to remove the solvent from the organic phase. The components of the reactor contents may vary between the acylation step and the cyclization step, the use of the solvent in the acylation step and the cyclization step, and so on, depending on the purification method. The two-phase separation of the reactor contents extracts the pyrazole compound into the organic phase. This organic phase can also contain the organic base and the organic solvent (if used) that were used in the acylation step. On the other hand, an eliminated secondary amine, for example dimethylamine, is extracted into the aqueous phase. The inorganic fluoride, for example potassium fluoride, an inorganic hydroxide and the hydrazine can also be contained in the aqueous phase. It is possible to obtain the pyrazole compound by flash distillation of the organic phase. In this case, the distilled solvent containing the base can be reused in the acylation step. Alternatively, it is feasible to recover the pyrazole compound by washing the organic phase with water to remove the organic base therefrom and then distilling off the solvent from the organic solvent. The pyrazole compound thus purified can also be subjected to drying by heating or under reduced pressure.
    It is possible to remove the isomer (1,5-disubstituted pyrazole-4-carboxylic acid ester) contained in the 1,3-disubstituted pyrazole-4-carboxylic acid ester by crystallization using a solvent. Alternatively, it is possible to convert the 1,3-disubstituted pyrazole-4-carboxylic acid ester and its isomer into 1,3-disubstituted pyrazole-4-carboxylic acid by hydrolysis and then to obtain the 1,3-disubstituted pyrazole-4-carboxylic acid ester by recrystallization . The 1,3-disubstituted pyrazole-4-carboxylic acid ester can also be purified using an adsorption column and so on.
    It is effective to wash the 1,3-disubstituted pyrazole-4-carboxylic acid ester produced in the present production method with a non-polar solvent. The 1,3-disubstituted pyrazole-4-carboxylic acid ester can be purified to a high purity of 99.9% or higher by washing with the non-polar solvent instead of recrystallization treatment. There is no particular limitation on the non-polar solvent. Examples of the non-polar solvent are hydrocarbons such as cyclohexane, pentane, hexane and heptane. The washing is preferably carried out at a temperature of 0 to 25 ° C. If the washing temperature is lower than 0 ° C, the contamination removal efficiency may be poor. When the washing temperature is higher than 25 ° C, the 1,3-disubstituted pyrazole-4-carboxylic acid ester can be eluted and the recovery rate can be reduced. Any washing technique can be introduced, for example, stirring washing, pouring washing, or a combination thereof. It is preferable to first carry out stirring washing, filtration, and then pouring washing.
    However, it is feasible to remove the polar substance or a specific impurity by dissolving the 1,3-disubstituted pyrazole-4-carboxylic acid ester containing the 1,5-isomer in an organic solvent and then dissolving the resulting treating solution is brought into contact with hydrochloric acid. In this case, the organic solvent preferably has low water solubility. Examples of such an organic solvent are benzene, toluene, xylene, ethylbenzene, diisopropyl ether, methylene chloride and chloroform. Toluene or xylene is preferred among others. The treating solution can be prepared by mixing the pyrazole compound with the above solvent. In the case where the organic solvent is contained in the reactor contents after the cyclization step, the reactor contents can be directly subjected to washing with water to remove the secondary amine and so on therefrom. The contact temperature is generally 0 to 80 ° C. It is enough to set the contact temperature to a normal temperature without heating or cooling. Although there is no particular limitation on the capacity ratio of the treatment solution and the hydrochloric acid, the capacity ratio of the treatment solution and the hydrochloric acid is preferably in the range of 9/1 to 1/1. If the amount of the hydrochloric acid used exceeds the above range, the space efficiency of the contact treatment may be deteriorated. If the amount of the hydrochloric acid used is less than the above range, an unfavorable result such as increase in treatment time or inadequacy in treatment efficiency may occur. The treatment time varies depending on the content of the polar substance, etc., the concentration of hydrochloric acid, the capacity ratio of the treatment solution and hydrochloric acid, the mixing state of the treatment solution, etc. In general, the treatment time ranges from 30 minutes to 3 hours. The contact treatment can be carried out by any means such as a normal stirring tank, static mixer, or circulating pump system. It is easy to carry out the contact treatment by mixing the treating solution with the hydrochloric acid in a stirring tank, allowing the resulting solution to stand, and thereby separating the polar substance or the specific impurity. The pyrazole compound can be recovered after the contact treatment by separating the organic treatment solution from the hydrochloric acid or distilling the solvent from the organic treatment solution.
    Examples
    The present invention will hereinafter be described in more detail with reference to the following examples. It should be emphasized that the following examples are illustrative and are not intended to limit the present invention thereto. Analysis of organic substances in each reaction solution was carried out by a gas chromatograph (with an FID detector). The results of the compositional analysis are given in units of area%. The content of ethyl 2- (difluoroacetyl) -3- (dimethylamino) acrylate (DFAAE) in the reaction solution was determined based on the mass of a solid substance obtained by distilling off toluene from the reaction solution after washing the reaction solution with water , certainly.
    [Comparative Example 1]
    A 500 ml three-necked flask was fitted with a dropping funnel and thermometer and sealed under a nitrogen balloon. To this flask were added 9.0 g of water, 100 ml of toluene and 6.0 g (0.13 mol) of monomethylhydrazine. The resulting solution was cooled to -10 ° C or below with stirring in a low-temperature thermostat the temperature of which was set to -15 ° C. Then, 110 g of a toluene solution containing 22.6 mass% of ethyl 2- (difluoroacetyl) -3- (dimethylamino) acrylate (DFAAE) was dropped into the flask through the dropping funnel, the dropping rate of the toluene solution being regulated in this way that the internal temperature of the flask did not rise above -10 ° C. After the completion of the dropping, the reaction was continued for 1 hour at -12 ° C. The internal temperature of the flask was then raised to 0 ° C. The reaction solution thus obtained was separated by adding 100 ml of water. The organic phase was collected through a separatory funnel and washed with 100 ml of water to obtain a toluene solution (193 g).
    The toluene solution obtained above was analyzed with a gas chromatograph. As a result, it was confirmed that: the content of ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate (target compound, 1,3-isomer) was 9.7 area%; the content of ethyl 5- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate (1,5-isomer) was 0.7 area% and the content of other compounds, except toluene, was 0.03 area -% was. The ratio of the target compound to the isomer was 93.7: 6.7. Next, 100 ml of the toluene solution as a sample was placed in a colorimeter and visually compared with standard Hazen solutions. The number of the standard Hazen solution closest to the sample in color was 500. In addition, the toluene solution was also compared with JIS color samples. Among the JIS color samples, the color of the toluene solution came closest to a strongly reddish "Himawari-iro".
    [Example 1]
    The same experiment as that of Comparative Example 1 was carried out, except that an aqueous solution of NaOH (1.8 g) in 9.0 g of water was used in place of 9.0 g of water; thereby a toluene solution (191 g) was obtained.
    The toluene solution obtained above was analyzed by a gas chromatograph. As a result, it was confirmed that: the content of the target compound was 9.58 area%; the content of 1,5-isomer was 0.02 area%, and the content of other compounds except toluene was 0.01 area%. Next, 100 ml of the toluene solution as a sample was placed in a colorimeter and visually compared with standard Hazen solutions. The number of the standard Hazen solution closest in color to the sample was 300. In addition, the toluene solution was also compared with JIS color samples. The color of the toluene solution came closest to “Kariyasu-iro” and was therefore less reddish than that of Comparative Example 1.
    In addition, the toluene solution was concentrated using a rotary evaporator, 25 g of hexane were added and the mixture was stirred at 5 ° C. for 1 hour with a magnetic stirrer. The resulting precipitate was filtered off, washed with hexane and dried under vacuum to obtain 17.7 g of a white crystal. This crystal was dissolved in acetone and analyzed with a gas chromatograph. It was confirmed that the content of ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate in the crystal was 99.9 area%.
    [Production Example (Production of Standard Hazen Solutions)]
    The standard Hazen solutions used in Comparative Example 1 and Example 1 as shown in Table 1 were prepared by using a color standard solution (1000 degrees) manufactured by Kanto Chemical Co., Ltd. , was diluted with distilled water. Standard Hazen No. 300 solution was prepared, for example, by adding 30 ml of the starting color standard solution to a volumetric flask and diluting the solution to 100 ml with distilled water. The same goes for the others.
    The test results of Comparative Example 1 and Example 1 are shown in Table 1.
    Table 1
    1,3-isomer: ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate1,5-isomer: ethyl 5- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate
    As can be seen from Table 1, the 1,3-disubstituted pyrazole-4-carboxylic acid ester was efficiently produced with less discoloration by reacting the 2-acyl-3-monoacrylic acid ester with the hydrazine in the presence of the base.
    [Synthesis Example 1]
    Synthesis of ethyl 2- (difluoroacetyl) -3- (dimethylamino) acrylate (DFAAE)
    A 2000 ml three-necked flask was fitted with a blow tube, thermometer, and dry ice condenser, and sealed with nitrogen. Into this flask were added 143 g of ethyl 3-N, N-dimethylaminoacrylate (DMAE), 570 g of toluene and 111 g of triethylamine (Et3N). The resulting solution was stirred with cooling the flask in a water bath at 20 ° C. Thereafter, 111 g of difluoroacetic acid fluoride (purity: 95%) were introduced into the flask reactor through the blow pipe at a rate of 1 g / min. After the completion of the introduction, the reaction was continued and completed for 1 hour by stirring the reaction solution at 30 ° C.
    The amount of the contents of the reactor (reaction solution) thus obtained was 927 g. The reaction solution was analyzed by a gas chromatograph. As a result, it was confirmed that: the content of DFAAE was 8.22 area%; the total content of Et3N and a salt of Et3N and hydrogen fluoride (Et3NnHF salt) was 10.48 area% (the Et3NnHF salt showed a broad peak of about 1 area%). The content of DMAE was 0.082 area% and the content of toluene was 80.62 area%.
    [Comparative Example 2]
    A 500 ml three-necked flask was fitted with a dropping funnel and thermometer and sealed under a nitrogen balloon. To this flask were added 9.0 g of water, 100 ml of toluene and 6.0 g (0.13 mol) of monomethylhydrazine. The resulting solution was cooled with stirring to -10 ° C or below in a low-temperature thermostat whose temperature was set to -15 ° C. Thereafter, 102 g of the solution obtained in Synthesis Example 1 (reaction solution, DFAAE: 0.11 mol) was gradually dropped into the flask through the dropping funnel so that the internal temperature of the flask did not exceed -10 ° C. After completion of the dropping, the reaction solution was kept at -12 ° C for 1 hour with stirring. The internal temperature of the flask was then raised to 0 ° C. The reaction solution was then separated by adding 100 ml of water. The organic phase was collected through a separatory funnel, washed with 100 ml of water, dried with magnesium sulfate and then subjected to filtration and solvent distillation. As a result, 21.0 g of a crude pyrazole was obtained (yield of crude product: 93.6%). The crude pyrazole was dissolved in acetone. The acetone solution thus obtained was analyzed by a gas chromatograph. As a result, it was confirmed that the total pyrazole purity (that is, the total purity of ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate and ethyl 5- (difluoromethyl) -1-methyl-1H pyrazole-4-carboxylate) was 99.1 area%. The ratio of the 1,3-isomer to the 1,5-isomer was 30.4: 69.6. In the synthesis of the pyrazole from DMAE, the overall yield of pyrazole was 92.7% and the yield of 1,3-isomer was 28.2%.
    [Example 2]
    The same experiment as that of Comparative Example 2 was carried out, except that an aqueous solution of 8.6 g of potassium hydroxide (KOH, 1.4 equivalents based on DFAAE) in 9.0 g of water instead of 9.0 g of water was used. In this experiment, 20.5 g of crude pyrazole was obtained (yield of crude product: 91.4%). The crude pyrazole was dissolved in acetone. The acetone solution thus obtained was analyzed by a gas chromatograph. As a result, it was confirmed that the total pyrazole purity was 99.3 area%. The ratio of the 1,3-isomer to the 1,5-isomer was 98.5: 1.5. In the synthesis of the pyrazole from DMAE, the overall yield of pyrazole was 90.7% and the yield of the 1,3-isomer was 89.4%.
    [Example 3]
    The same experiment as that of Comparative Example 2 was carried out, except that an aqueous solution of 6.2 g of sodium hydroxide (NaOH, 1.4 equivalents based on DFAAE) in 9.0 g of water instead of 9.0 g of water was used. In this experiment, 21.5 g of a crude pyrazole was obtained (yield of crude product: 95.8%). The crude pyrazole was dissolved in acetone. The acetone solution thus obtained was analyzed by a gas chromatograph. As a result, it was confirmed that the total pyrazole purity was 72.6 area%. The ratio of the 1,3-isomer to the 1,5-isomer was 92.7: 7.3. In the synthesis of the pyrazole from DMAE, the overall pyrazole yield was 69.6% and the yield of the 1,3-isomer was 64.5%.
    [Example 4]
    The same experiment as that of Comparative Example 2 was carried out, except that a solution of Et3N (11 g) in 9.0 g of water was used instead of 9.0 g of water. In this experiment, 20.6 g of a crude pyrazole was obtained (yield of crude product: 91.8%). The crude pyrazole was dissolved in acetone. The acetone solution thus obtained was analyzed by a gas chromatograph. As a result, it was confirmed that the total pyrazole purity was 96.3 area%. The ratio of the 1,3-isomer to the 1,5-isomer was 59.6: 40.4. In the synthesis of the pyrazole from DMAE, the overall yield of pyrazole was 88.4% and the yield of the 1,3-isomer was 52.7%.
    [Reference Example 1]
    A solution of DFAAE in toluene was obtained in an amount of 384 g by washing 463 g of the reaction solution obtained in Synthesis Example 1 twice with 250 g of water. When 10 g of this solution was subjected to solvent distillation, 2.45 g of DFAAE was obtained. Based on the theoretical yield of DFAAE in the reaction of Synthesis Example 1, the recovery rate of DFAAE by washing with water was 90%.
    Thereafter, the same experiment as that of Comparative Example 2 was carried out by using 113 g of the DFAAE-toluene solution (DFAAE: 0.12 mol) obtained above without changing the amounts of the other substrates. In this experiment, 21.3 g of a crude pyrazole were obtained (yield of crude product: 87.0%). The crude pyrazole was dissolved in acetone. The acetone solution thus obtained was analyzed by a gas chromatograph. As a result, it was confirmed that the total pyrazole purity was 99.5 area%. The ratio of the 1,3-isomer to the 1,5-isomer was 92.5: 7.5. In the synthesis of the pyrazole from DMAE, the total yield of pyrazole was 86.6% and the yield of the 1,3-isomer was 80.1%.
    The test results of Comparative Example 2, Examples 2 to 4 and Reference Example 1 are shown in Table 2.
    Table 2
    Table 2
    1,3-isomer: ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate1,5-isomer: ethyl 5- (difluoromethyl) 1-methyl-1H-pyrazole-4-carboxylateDFAAE: ethyl 2- (difluoroacetyl) -3- (dimethylamino) acrylateTotal Pyrazole Yield: Total yield of 1,3-isomer and 1,5-isomerYield of total pyrazole (%) = {amount of crude pyrazole (g) x pyrazole rate (area%)} / {DFAAE (mol) x 204 (molecular weight)}Yield (%) of 1,3-isomer = Yield of total pyrazole (%) x (isomer ratio of 1,3-isomer)
    As can be seen from Table 2, the 1,3-disubstituted pyrazole-4-carboxylic acid ester was produced more efficiently by using the inorganic base than by using the organic base in the cyclization reaction. When the cyclization reaction was carried out by adding the inorganic base without removing the salt obtained by the acylation reaction from the reactor contents, the 1,3-disubstituted pyrazole-4-carboxylic acid ester became efficient by limiting the generation amount of the 1,5-isomer receive.
    <Synthesis Example 2>
    A 1000 ml three-necked flask was fitted with a blowpipe, a thermometer and a dry ice condenser and sealed with nitrogen. Into this flask were added 72 g of ethyl 3-N, N-dimethylaminoacrylate (DMAE), 285 g of toluene and 56 g of triethylamine (Et3N). The resulting solution was stirred while the flask was cooled in a water bath. Then, 56 g of difluoroacetic acid fluoride (purity: 95%) was introduced into the flask reactor through the blow pipe at a rate of 0.5 g / min. After the completion of the introduction, the reaction was continued and completed for 1 hour by stirring the reaction solution at 30 ° C.
    The amount of the contents of the reactor (reaction solution) thus obtained was 463 g. The reaction solution was washed twice with 250 g of water to remove Et3NnHF salt therefrom. 382 g of a 25.9% by mass DFAAE-toluene solution were thus obtained.
    A 2000 ml three-necked flask was fitted with a dropping funnel and thermometer and sealed under a nitrogen balloon. Into this flask were added 36.0 g of water, 6.4 g of sodium hydroxide, 400 ml of toluene and 24.0 g (0.52 mol) of monomethylhydrazine. The resulting solution was cooled to -10 ° C or below with stirring in a low-temperature thermostat the temperature of which was set to -15 ° C. Then, 375 g of the DFAAE-toluene solution (DFAAE: 0.11 mol) washed with water was gradually dripped into the flask through the dropping funnel so that the internal temperature of the flask did not exceed -10 ° C. After completion of the dropping, the solution was kept at -12 ° C for 1 hour with stirring. The internal temperature of the flask was then raised to 0 ° C. The solution thus obtained was separated by adding 400 ml of water. The organic phase was collected through a separatory funnel and washed with 400 ml of water, whereby 702 g of a 9.7 mass% pyrazole-toluene solution was obtained.
    <Examples 1 to 4 for washing with hydrochloric acid>
    Into a three-necked flask equipped with a thermometer and a reflux condenser were placed 150 g of the pyrazole-toluene solution obtained in Synthesis Example 2 and 50 g of hydrochloric acid having a concentration shown in Table 1 (35 mass%, 25 mass%, 17 mass -%, 10 mass%). The resulting mixture was stirred for 1 hour at room temperature (25 ° C). Thereafter, the separated organic phase was concentrated. The crude pyrazole thus obtained was analyzed by high performance liquid chromatography (HPLC) according to the following analysis method and sample preparation method.
    <HPLC analysis method>
    Analytical device: Agilent HP-1000 LC systemFlow rate: 1 ml / min6 mM methanesulfonic acid: ACN = 6: 4, gradually changed to 3: 7 over 30 minutesUV detector: λ = 210 nmColumn: Cadenza CD-C18 (diameter: 4.6 mm, length: 250 mm, particle size: 3 µm)Temperature: 35 ° C
    <Sample preparation method>
    A sample was taken and purged with nitrogen to remove the solvent therefrom. Then the weight of the sample was measured. Then, a mobile phase was added to the sample to a concentration of 2 mg / ml (6 mM methanesulfonic acid: ACN = 6: 4), followed by uniformly dissolving the sample in the mobile phase. The resulting sample solution was subjected to analysis.
    The test results of Examples 1 to 4 of washing with hydrochloric acid are shown in Table 3.
    Table 3
    [0115] Table 3 (continued)
    3.51: ethyl 3-N, N-dimethylaminoacrylate3.74: 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid7.37: ethyl 2- (difluoroacetyl) -3- (dimethylamino) acrylate8.52: ethyl 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate12,32: ethyl 5- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylate
    As can be seen from Table 3, the 1,3-disubstituted pyrazole-4-carboxylic acid ester was purified efficiently by washing / bringing the reaction solution into contact with hydrochloric acid.
    As described above, in the present invention, it is possible to produce the 1,3-disubstituted pyrazole-4-carboxylic acid ester with high yield and selectivity and with less coloration. It is also possible to limit the amount of an isomer (1,5-disubstituted pyrazole-4-carboxylic acid ester) in the product in the present invention to a low level.
    Industrial applicability
    The process according to the present invention can be used for the preparation of a pyrazole compound which can be used as an intermediate for pharmaceutical and agrochemical products.
    权利要求:
    Claims (12)
    [1]
    A method for producing a pyrazole compound of the general formula (5), comprising: a reaction step of reacting a 2-acyl-3-aminoacrylic acid ester of the general formula (1) with a hydrazine of the general formula (4) in the presence of a base
    wherein R 1 is a halogenated alkyl group, and R 2, R 3 and R 4 are each independently an alkyl group,
    where R <5> is an alkyl group or an aryl group,
    in which R 1, R 4 and R 5 have the same meanings as above.
    [2]
    2. The method for producing a pyrazole compound according to claim 1, wherein the base is an inorganic base.
    [3]
    3. The method for producing a pyrazole compound according to claim 2, wherein the base is an alkali metal hydroxide.
    [4]
    4. The method for producing a pyrazole compound according to any one of claims 1 to 3, wherein R <1> is a halogenated alkyl group having 1 to 10 carbon atoms.
    [5]
    5. The method for producing a pyrazole compound according to claim 4, wherein R <1> is a fluoroalkyl group having 1 to 4 carbon atoms.
    [6]
    6. The method for producing a pyrazole compound according to claim 5, wherein R <1> is a trifluoromethyl group or a difluoromethyl group.
    [7]
    7. The method for producing a pyrazole compound according to claim 4, wherein R <1> is a chloroalkyl group having 1 to 4 carbon atoms.
    [8]
    8. The method for producing a pyrazole compound according to claim 7, wherein R <1> is a dichloromethyl group.
    [9]
    9. A method for producing a pyrazole compound according to any one of claims 1 to 8, wherein the reaction step comprises the following two steps:a first step of obtaining a reactor content containing the 2-acyl-3-aminoacrylic acid ester of the general formula (1) by reacting a carboxylic acid halide of the general formula (2) with a dialkylaminoacrylic acid ester of the general formula (3) in the presence of an organic base
    wherein R <1> has the same meaning as in the general formula (1),
    wherein R 2, R 3 and R 4 have the same meanings as in general formula (1), anda second step of forming a pyrazole compound of the general formula (5) by mixing the reactor contents obtained by the first step, an inorganic base as the base and a substituted hydrazine as the hydrazine of the general formula (4).
    [10]
    10. The method for producing a pyrazole compound according to claim 9, wherein, in the second step, the pyrazole compound of the general formula (5) is mixed with a composition containing the reactor content obtained by the first step and the base a second composition containing the substituted hydrazine is formed.
    [11]
    11. The method for producing a pyrazole compound according to claim 9 or 10, wherein the organic base used in the first step is a tertiary amine, and wherein the inorganic base used in the second step is either potassium hydroxide or sodium hydroxide is.
    [12]
    12. A method for producing a pyrazole compound according to any one of claims 9 to 11, wherein the carboxylic acid halide of the general formula (2) is difluoroacetic acid fluoride.
    类似技术:
    公开号 | 公开日 | 专利标题
    EP1644314B1|2011-08-10|Method for producing difluoro-acetyl-acetic acid alkylesters
    EP1852424B1|2012-04-04|Method for manufacturing isoxazoline-3-yL-acyl benzoles
    DE60125747T2|2007-05-16|PROCESS FOR THE PREPARATION OF 2-HALOBENZOIC ACIDS
    CH706864B1|2016-03-31|Process for producing a pyrazole compound.
    WO2011157664A1|2011-12-22|Process for preparing tetrazole-substituted anthranilamide derivatives and novel crystal polymorph of these derivatives
    WO1999012911A1|1999-03-18|Method for producing |aromatic hydroxylamines
    WO2018104214A1|2018-06-14|Method for producing 5-|-nicotinamide derivatives and similar compounds without isolating or purifying the phenylhydrazine intermediate
    WO2010081865A1|2010-07-22|Separation of an enantiomer mixture of |- and |-3-amino-1-butanol
    EP2370397B1|2013-01-16|Process for removing by-products from n-vinylamides
    EP2822924B1|2019-12-04|Process for the synthesis of aminobiphenyls using arylhydrazines
    DE10331496A1|2005-01-27|Process for preparing alkyl difluoroacetoacetates
    EP1606246B1|2010-05-19|Method for producing 2-cyan-3-hydroxy-n-|but-2-ene amides
    EP1129082B1|2004-09-29|Method and novel intermediate products for producing isoxazolin-3-yl-acylbenzenes
    EP1957443A2|2008-08-20|Method for producing sulfonamides
    DE112016003289T5|2018-04-12|PROCESS FOR PREPARING A 4- | PHENOL COMPOUND
    WO2014187791A1|2014-11-27|Improved method for producing specific oximes and oximethers
    DE60110807T2|2005-10-20|CONTINUOUS METHOD FOR THE PREPARATION OF PESTICIDE CHLORTHIAZOLS
    EP1481958B1|2008-03-26|Production of organic compounds which are low in fluoride
    EP0612316B1|1997-02-05|Process for preparing 3|-methylpyrazoles
    EP2342174B1|2013-03-27|Method for producing 3-aminobiphenylene
    EP0759429A1|1997-02-26|Substituted trifluormethylpyridines useful as intermediates for herbicidal 1-|-pyrazoles
    JP2013006779A|2013-01-10|Method for producing pyrazole compound
    EP2546229A1|2013-01-16|Method for synthesising aminobiphenyls
    DE102005035301A1|2007-02-01|Preparation of trifluoromethylphenacyl bromide comprises reacting trifluoromethylacetophenone compound with brominating agent in the absence of solvent or in the presence of hard water soluble/water-immiscible solvent and crystallizing
    DE60223683T2|2008-10-30|3,3-DIALKOXY-2-HYDROXYIMINOPROPIONIC ACIDITRILE, METHOD FOR THE PRODUCTION AND METHOD FOR THE PRODUCTION OF 5-AMINO-4-NITROSOPYRAZOLENE BZW. SALTS OF IT UNDER OPERATION OF THESE CONNECTIONS
    同族专利:
    公开号 | 公开日
    DE112012002522T5|2014-03-13|
    CN103635461B|2016-01-20|
    WO2012176717A1|2012-12-27|
    US9012657B2|2015-04-21|
    CN103635461A|2014-03-12|
    US20140107347A1|2014-04-17|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    JPH0820560A|1994-07-07|1996-01-23|Shin Etsu Chem Co Ltd|Production of ester compound|
    JP2000128763A|1998-10-28|2000-05-09|Kose Corp|Antimicrobial composition and skin preparation for external use containing the same|
    JP2000212166A|1999-01-26|2000-08-02|Mitsui Chemicals Inc|Production of 1,3-dialkylpyrazole-4-carboxlic acid ester|
    DE10161978A1|2001-12-17|2003-06-26|Bayer Ag|Preparation of 2-haloacyl-3-amino-acrylic acid ester preparation, for use as intermediates for drugs and/or agrochemicals, from N-substituted 3-amino-acrylic acid ester and haloalkanoic acid anhydride|
    DE10349500A1|2003-10-23|2005-06-02|Bayer Cropscience Ag|A process for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters|
    CN101133031B|2005-02-25|2010-07-21|财团法人相模中央化学研究所|Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate|
    JP5031817B2|2006-03-22|2012-09-26|エフ．ホフマン−ラロシュアーゲー|Pyrazole as 11β-HSD1|
    BRPI0720410A2|2006-12-21|2013-12-31|Basf Se|PROCESSES FOR PREPARATION OF COMPOUND, FOR PREPARATION OF MILES, AND COMPOUNDS.|
    TW200836719A|2007-02-12|2008-09-16|Astrazeneca Ab|Chemical compounds|
    US7652004B2|2007-08-09|2010-01-26|Bristol-Myers Squibb Company|Compounds for the treatment of hepatitis C|
    EP2133341A1|2008-02-25|2009-12-16|Bayer CropScience AG|Method for regioselective synthesis of 1-alkyl-3-haloalkyl-1-pyrazol-4-carbonic acid derivatives|
    JP5388338B2|2009-03-02|2014-01-15|株式会社オプナス|Button lock|
    JP5605104B2|2010-09-10|2014-10-15|セントラル硝子株式会社|Method for producing pyrazole compound|US8871947B2|2013-02-04|2014-10-28|KingChem LLC|Preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ester|
    CN104379551B|2013-12-09|2017-03-08|金凯有限责任公司|The preparation method of 3 difluoromethyl, 1 methyl 1H pyrazoles 4 alkyl carboxylates and the like|
    CN103936673B|2014-03-27|2016-06-29|华东师范大学|A kind of 1,4,5-tri-substituted pyrazolecarboxylic compounds and preparation method thereof|
    CN104529899A|2014-12-19|2015-04-22|浙江泰达作物科技有限公司|Method for preparing 1-alkyl-3-halogenated alkyl pyrazole derivative with high regioselectivity|
    CN105541716A|2015-03-26|2016-05-04|旭硝子株式会社|Manufacturing method for pyrazole derivatives|
    法律状态:
    2020-01-31| PL| Patent ceased|
    优先权:
    申请号 | 申请日 | 专利标题
    JP2011138740A|JP2013006779A|2011-06-22|2011-06-22|Method for producing pyrazole compound|
    JP2011138737A|JP5915004B2|2011-06-22|2011-06-22|Method for producing pyrazole compound|
    PCT/JP2012/065459|WO2012176717A1|2011-06-22|2012-06-18|Method for producing pyrazole compound|
    [返回顶部]